Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Gains from Investment Securities (2020 - 2025)

Beauty Health (SKIN) has disclosed Gains from Investment Securities for 6 consecutive years, with $187000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 8.33% to $187000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.4 million, a 144.52% decrease, with the full-year FY2024 number at -$3.1 million, down 235.17% from a year prior.
  • Gains from Investment Securities was $187000.0 for Q3 2025 at Beauty Health, down from $708000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $72.0 million in Q2 2021 to a low of -$71.8 million in Q3 2021.
  • A 5-year average of -$4.4 million and a median of $37500.0 in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 255.86% in 2023, then crashed 3509.82% in 2024.
  • Beauty Health's Gains from Investment Securities stood at -$969000.0 in 2021, then tumbled by 604.02% to -$6.8 million in 2022, then surged by 255.86% to $10.6 million in 2023, then crashed by 142.85% to -$4.6 million in 2024, then soared by 104.1% to $187000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Gains from Investment Securities are $187000.0 (Q3 2025), $708000.0 (Q2 2025), and $250000.0 (Q1 2025).